Takeaway: Here are Hedgeye CEO Keith McCullough's refreshed levels for our high-conviction stock ideas.
Trade :: Trend :: Tail Process - These are three durations over which we analyze investment ideas and themes. Hedgeye has created a process as a way of characterizing our investment ideas and their risk profiles, to fit the investing strategies and preferences of our subscribers.
Anything longer than 3 years is unpredictable.
Takeaway: Current Investing Ideas: DRI, HCA, HOLX, LM, LO, OC, RH, and ZQK
Below are Hedgeye analysts' latest updates on our EIGHT current high-conviction investing ideas. We also feature three research notes from earlier this week which offer valuable insight into the markets and two particular stocks.
*Please note we removed CCL from Investing Ideas this week..
*We will send CEO Keith McCullough's updated levels for each stock in a separate email this weekend.
DRI – Managing Director Howard Penney got the news he was looking for on Tuesday, when Starboard Value LP announced it had secured enough votes to call a special shareholder meeting. The goal of this meeting is to stop the proposed Red Lobster spinoff which would potentially destroy significant shareholder value. Darden will have 60 days to call the meeting.
Starboard reportedly received 55.5% of the vote. Although this may look like a slim margin of victory, it is actually quite overwhelming considering the turnover since the record date, the amount of shares short and the retail component. Starboard Managing Member, Chief Executive Officer and Chief Investing Officer, Jeffrey C. Smith, was very clear about what he believes needs to happen at Darden. According to him, Mr. Otis is in a hot seat and deservedly so – just look at the chart below. Many have remarked that Mr. Otis is losing control of the company; ironically, that just took on a whole new meaning.
Although we may see some near-term volatility as this situation plays out, we remain bullish on Darden as a long-term investment.
HCA – We had flagged rising surgical case volume as a near term reason to remain positive on HCA Holdings coming out of their Q413 earnings. We had specifically noted the acceleration in US Orthopedic sales and what appeared to be a durable relationship with some of our macro data series.
Fast forward to UHS results on Friday and that looks like the right bet. This week both SYK and ZMH put up some decent numbers in their US franchises, although trends slowed modestly. Meanwhile, UHS in talking about a 6.3% increase in revenue per adjusted admission cited ”strengthening surgical volumes,” and fewer “uninsured patients and more Medicaid and commercial insurance patients.” UHS tells us a lot about HCA ahead of their release next week where we are now more convinced we’ll see some upside to numbers. In the chart below you’ll see the same-store revenue per adjusted admission growth rate for the two companies. Coming into hospital earnings the concerns have been the foul weather of Q114 and the Affordable Care Act not delivering much upside. Our data suggested weather was less of an issue than feared and the Affordable Care Act is not the most important driver. Turns out we were right to focus on surgical volume.
HOLX – We believe Hologic will have a good quarter in their Breast Health segment driven by Digital Breast Tomosynthesis products, when they report earnings. We’ve developed a proprietary way to track placements month to month and the March quarter looks like their best yet. There is plenty of noise in their other businesses these days to keep in perspective, however.
The first was this week’s approval of Roche’s HPV test as a first line screen for cervical cancer. Traditionally the Pap test, which HOLX dominates with their ThinPrep test, has been the first line screen which is then followed by an HPV test for confirmation. In some ways it makes more sense to screen for cervical cancer by looking directly for the virus that causes the disease first and then do the Pap test if the patient tests positive. The problem however is that HPV infection is really common, particularly among sexually active women, and is usually harmlessly cleared by the body. The point is that sorting this out will take a very long time. OB/GYNs are already coping with guideline changes for the recommended interval between negative test result. ThinPrep volume is already down in the mid teens and becoming less important by the quarter. We’re following this closely with a monthly survey, so we should see it coming if things get even worse from here, but we doubt that will happen.
Which brings us back to Breast Health and the DBT trend. After speaking to a number of experts in the field recently we are getting more confident that the reimbursement Medicare will give DBT this Fall will be high enough to drive a rapid adoption of DBT. In the short run, we are keeping our eye on negative news items such as the Roche HPV approval, but we’re also keeping it in perspective. We think the story is DBT and we think they’re having a good quarter.
LM – We have no material update on our recommendation of Legg Mason as a core long for retail investors. We think that the theme of getting exposure to a defensive bond manager is slowly making its way into the asset management stocks as Legg is the only positive performer in the group year to date. LM stock is up 5.5% thus far in 2014 versus the group average of a decline of 4.4%. We estimate that Legg shares are worth over 20% higher than current prices on an intermediate to long term basis as we see earnings results over 10% higher than our Street competitors and also some multiple expansion on this out of favor stock.
LO – Lorillard reported Q1 2014 results on Thursday that were lukewarm, missing Street estimates on the top and bottom lines, however the stock closed up on the day.
Our long-term bullish outlook remains unchanged and built on 1) the strength and profitability of its advantaged menthol portfolio, 2) our belief in the limited menthol regulatory risk over the longer term, and 3) upside growth in its blu e-cigarette business that commands leading share in the U.S.
CEO Murray Kessler recognized that the convergence of numerous headwinds impacted the quarter’s results: for cigarettes lower wholesale inventory levels, severe weather affecting core markets, a tax increase in Puerto Rico and holiday timing (Easter), as well as in e-cigs lower prices of its rechargables kits and pipeline inventory build versus the year ago-quarter.
All that said, LO had impressive price/mix of +5.8% to offset total cigarette volume decline of -2.9% (outperforming the total industry at -4.0%). Total LO retail market share in the quarter rose 30bps to 15.2%, its highest level ever and its first quarter above 15%, and Newport’s share grew 40bps to 13% while LO’s share of the menthol market was flat Y/Y at 40.7%, but improved 80bps sequentially.
While its e-cig blu contributed a $0.02 loss in the quarter and sales fell for a second straight quarter, the company announced a $10-20MM spend over next 6 to 9 months to rebrand its ownership in SKYCIG in the U.K. as blu and continue to support incremental brand building for blu in the U.S. The playing field in the U.K. is decidedly fragmented, yet the second largest e-cig market behind the U.S. We like LO’s strategy to invest early in its e-cig business to become category leaders.
OC – Owens Corning missed consensus estimates on both top and bottom line mostly stemming from poor weather. So is weather a valid excuse? We think so. It is quite hard to install insulation or roofing products in snow and ice. As a result, the segment data can be quite noisy shown in the graph below. More importantly, we saw margin improvement in its two core segments: Insulation and Composites. Margins held steady and/or improved in a challenging environment bodes well for OC. 2Q should see higher volume across OC’s segments as construction activity picks up heading into the summer. FY 2014 guidance remains unchanged, but is now expected on the lower end. It is hard to put too much weight on 1Q results, but OC will need to deliver in 2Q.
RH – Restoration Hardware had a notable personnel event this week, with the appointment of Dr. Leonard Schlesinger to its Board of Directors. Ordinarily we don’t comment on developments on a company’s Board. But this one is notable – especially given the concern that so many people have about the company’s executive ranks since the departure of its former Co-CEO last year. The new Board member is about as well-decorated as a company the size of RH could hope for. He was Vice Chairman/COO of Limited Brands from 1999 through 2007 and is currently a Professor at Harvard Business School. He has served in numerous other roles in both C-Suites and Academia. We like how well-rounded Schlessinger is – especially given some of the questionable Board appointments we see these days. This is very complimentary to the addition of Doug Diemoz last month as Chief Development Officer.
We don’t expect this to wipe away the concerns of all the people that think that Gary Friedman is a risk being the sole person at the top. But we think that will be addressed by one thing alone – the focus of the management team, and the company’s performance over the next year. Both of those should absolutely be there. In the end, by this time next year, we think that ‘management risk’ will be off the table for people considering RH as an investment (and a part of the short case will be taken out to pasture).
ZQK – On Friday VF Corp announced solid 1Q earnings, which we think has several implications for Quiksilver. First off, VFC is the biggest apparel company that most people never heard of. It owns 30 lifestyle brands including Wrangler, Lee, Timberland, Vans and The North Face. While it operates primarily through wholesale channels, it has 1,100 of its own retail stores across concepts throughout the globe.
So what applies to ZQK? 1) Every division at VFC missed expectations except its Outdoor/Action Sports coalition. Furthermore, the strongest brand in the quarter – and now officially the biggest brand in the portfolio – is Vans. That’s a good sign for the action sports space, and most specifically, ZQK’s DC Shoes division. 2) VFC particularly noted that it’s Southern European business is picking up – where ZQK is particularly strong. 3) Most importantly, this beat shows how important Action Sports is to VFC. There is no question in our minds that VFC will continue to be acquisitive in this space, and as it’s $11bn revenue base continues to grow there are not too many brands it can buy that will make a dent in the financial model. One of the few is ZQK. 4) Add that to the comment from Kering (owner of Gucci, Puma, Volcom, Tretorn, Cobra Golf, YSL, Alexander McQueen, etc…) that it is looking to acquire more sports brands, and that puts ZQK right in the sweet spot. It does not hurt that ZQK CEO Andy Mooney gets a $25mm payday if the stock breaks through $9.28.
We continue to believe that the brand will gain traction organically, until it is ultimately taken out in 1-2 years – likely at a low double-digit price. We think it’s a 2-year double.
* * * * * * *
Click on each title below to unlock the institutional content.
Macro analyst Christian Drake says at the midpoint in Q1 2014 earnings, the trends are looking very much the same as those that prevailed in Q4 2013.
Managing Director Howard Penney remains bullish on CMG, as it continues to take share in an ultra-competitive environment. Recent comp & traffic numbers are unheard of.
Retail Sector Head Brian McGough says DDS at $155 seems ridiculous. The asset play is maybe $50 on a great day. If people value DDS like a retailer again, the stock’s in trouble.
Relied upon by big institutional and individual investors across the world, this granular morning newsletter distills the latest and most vital market developments and insures that you are always in the know.
Takeaway: 63% YES; 37% NO.
“[Vladimir] Putin gets paid in Petro Dollars,” CEO Keith McCullough wrote in today’s Morning Newsletter. “I wouldn’t be surprised if he tries to solve the aforementioned trifecta of sovereign risk (Russian CDS up to 282 bps wide now – a 2 yr high) by firing up the geopolitical risk news flow.”
We know what we think here at Hedgeye. We wanted to know what you think. So we asked in today’s poll: Is Putin going to do something big to send oil prices higher?
At the time of this post, the votes leaned toward YES at 63%; 37% NO.
“What choice does he have?” asked one YES voter. “Failed bond offering; collapsing ruble; currency outflows. At a minimum he will force the market to react which, most likely, is all he wants.”
Another person who voted YES said, “Putin is not going to sit here and take a beating from the Western powers. He's a thug at heart, besides [retaliating] violently through war, the next best weapon is the oil price. He will make the Western economy suffer from high oil prices.”
On the other side, however, one NO voter argued that “Putin will act within his immediate sphere of control. He can manipulate oil/gas supply and prices in Ukraine/Germany etc but not likely to try - or succeed - on the world stage in a lasting way.”
Additionally, another NO voter questioned what Putin could do and that “almost all the Russian outcomes have already been considered by the big oil market participants.”
Or as this NO voter cleverly pointed out: “The truth is that no one has a crystal ball. But if the debate gets loud on whether he'll do something, the market will react and he might not have to.”
Earnings in 4Q13 were marked by two distinct trends.
At the midpoint in 1Q14 earnings, the trends are looking very much the same as those that prevailed in 4Q13.
BEAT-MISS: With ~50% of SPX constituent companies having reported 1Q14 results, the Sales BEAT-MISS spread is trailing both the 4Q and TTM averages while the EPS beat percentage stands at 74.5% - ahead of both the 4Q13 and TTM average of 72%.
Of course, as has been the case for the last 4 years, the progressive deflation of expectations ahead of the quarter remains the best means to manufacturing a “beat”.
This quarter has not been an exception as topline estimates for 1Q14 have drifted steadily lower for SPX constituents into and through the new year.
BEAT/MISS vs SUBSEQUENT PERFORMANCE: Of the minority of companies that have missed bottom line estimates, 81% have gone on to materially underperform (-3.2% on ave.) the market over the subsequent 3 trading days.
Similarly, 69% of companies missing topline estimates have subsequently underperformed the market by -2.9% on average over the following three days.
OPERATING PERFORMANCE: Despite the generally positive Beat-Miss trends, operating performance has once again been underwhelming with just 42% and 40% of companies registering sequential acceleration in sales and earnings growth, respectively.
Margin performance has been similarly unimpressive with only 47% of companies reporting sequential operating margin expansion according to bloomberg data.
From a sector perspective, Utilities and Energy have led operating performance while everyone else sits on the wrong side of the 50% Mendoza line.
STYLE FACTOR PERFORMANCE: From a style factor perspective, High Short Interest. Low Yield, and High Sales Growth names have performed notably better vs. prevailing topline expectations than their inverses.
Christian B. Drake
Hosted by Hedgeye CEO Keith McCullough at 9:00am ET, this special online broadcast offers smart investors and traders of all stripes the sharpest insights and clearest market analysis available on Wall Street.